Katerina Cheliotis

PhD Student (MRC DTP)

Katerina graduated with a BSc (Hons) in Biological and Medical Sciences in 2016 from the University of Liverpool. After graduating, she worked for a short period as a Journal Development Editor, managing a portfolio of open access journals at BioMed Central. Following this, she was awarded a training scholarship from Unilever to undertake a 6 month placement as a visiting research assistant in the Watt Lab at the Centre for Stem Cells and Regenerative Medicine, Kings College London.

In 2018, Katerina began the MRC Doctoral Training Programme at LSTM, with an integrated MRes at Lancaster University in Global Health: Quantitative and Translational Skills. Katerina is now undertaking her PhD with the Respiratory Clinical Research Group under the supervision of Professor Daniela Ferreira working on the development of novel pneumonia vaccines. During the COVID-19 pandemic (2020), Katerina undertook a secondment to support a number of SARS-CoV-2 clinical trials, including the ChAdOx1 Vaccine Trial. In 2018,

Katerina became co-founder and license holder of TEDxLSTM and was co-lead organiser of the inaugural TEDxLSTM event in November 2019.


Identifying novel pneumonia vaccine candidates

Katerina is a member of the Human Infection Challenge Network for Vaccine Development (HIC-Vac), which is funded by the GCRF Networks in Vaccines Research and Development, which was co-funded by the MRC and BBSRC.